Selective Inhibitors of 11 β-Hydroxysteroid Dehydrogenase Type 1 for Patients with Metabolic Syndrome: Is the Target Liver, Fat, or Both?

Diabetes

Volumn 58, Issue 1, 2009, Pages 14-15

  Stewart, Paul M ^a   Tomlinson, Jeremy W ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 1 INHIBITOR; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ENZYME INHIBITOR; HYDROCORTISONE; UNCLASSIFIED DRUG;

DIABETES MELLITUS; ENZYME INHIBITION; HUMAN; HYDROCORTISONE RELEASE; INTRAABDOMINAL FAT; ISOTOPE LABELING; METABOLIC SYNDROME X; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; ADIPOSE TISSUE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LIVER; METABOLISM; PATHOLOGY; SPLANCHNIC BLOOD FLOW;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; HUMANS; HYDROCORTISONE; INTRA-ABDOMINAL FAT; LIVER; METABOLIC SYNDROME X; SPLANCHNIC CIRCULATION;

EID: 63249113536     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1404     Document Type: Note

References (12)

1. Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM: Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33:1364-1368, 1999
2. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM: 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866, 2004
3. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B, Abrahmsen L: Selective inhibition of 11beta- hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45:1528-1532, 2002
4. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Eva BB, Abrahmsen LB: Selective inhibition of 11{beta}- hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762, 2003
5. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R: 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517-527, 2005
6. Berthiaume M, Laplante M, Festuccia W, Gelinas Y, Poulin S, Lalonde J, Joanisse DR, Thieringer R, Deshaies Y: Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 148:2391-2397, 2007
7. Hawkins M, Hunter D, Kishore P, Schwartz S, Hompesch M, Hollis G, Levy R, Williams B, Huber R: INCB013739, a selective inhibitor of 11β-hydrox- ysteroid dehydrogenase type 1 (11βHSD1), improves insulin sensitivity and lowers plasma cholesterol over 28 days in patients with type 2 diabetes mellitus (Abstract). Diabetes 57 (Suppl. 1):A99-A100, 2008
8. Stimson RH, Andersson J, Andrew R, Redhead DN, Karpe F, Hayes PC, Olsson T, Walker BR: Cortisol release from adipose tissue by 11β- hydroxysteroid dehydrogenase type 1 in humans. Diabetes 58:46-53, 2009
9. Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M, Singh R, Sarr M, Rizza RA: Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes 58:39-45, 2009
10. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL: Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry J Clin Endocrinol Metab 72:39 -45, 1991
11. Basu R, Edgerton DS, Singh RJ, Cherrington A, Rizza RA: Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11β hydroxysteroid dehydrogenase type 1 activity. Diabetes 55:3013-3019, 2006
12. Andrew R, Westerbacka J, Wahren J, Yki-Jarvinen H, Walker BR: The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 54:1364-1370, 2005